Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi Post author:Sam Post published:November 8, 2017 Post category:BioPharma Sanofi will write a check for $40 million upfront. Source: BioSpace You Might Also Like Puma Biotech Receives FDA Advisory Committee Support For Neratinib May 25, 2017 Keryx, Norwich Pharma Mutually Terminate Manufacturing Agreement December 27, 2017 COO and First Employee of Editas Medicine to Exit, Effective March 31 March 5, 2017
